| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.28 | 9e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 7e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |